Clinical Study of Tongxinluo Capsule in Preventing and Treating Restenosis After Intracranial and External Arterial Stenting

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2026

Conditions
Stent Restenosis
Interventions
DRUG

Tongxinluo capsule

On the basis of conventional treatment, the study participants in the experimental group were given Tongxinluo capsule for 12 months.

OTHER

Primary therapy

Routine oral aspirin enteric-coated tablets, clopidogrel bisulfate tablets and rosuvastatin calcium tablets (or atorvastatin calcium tablets)

All Listed Sponsors
lead

Yanbin Li

OTHER